Page last updated: 2024-08-05 12:30:32

N-acyl-L-amino acid

Any N-acylamino acid having L-configuration.

ChEBI ID: 21644

Members (8)

MemberDefinitionRole
(2S)-3-(1H-indol-3-yl)-2-[[2-[(4-methyl-6-oxo-3-benzo[c][1]benzopyranyl)oxy]-1-oxoethyl]amino]propanoic acid(2S)-3-(1H-indol-3-yl)-2-[[2-[(4-methyl-6-oxo-3-benzo[c][1]benzopyranyl)oxy]-1-oxoethyl]amino]propanoic acid
n-acetyl-s-(2-cyanoethyl)cysteineN-Acetyl-S-(2-cyanoethyl)-cysteine
n-acetyl-s-(propionamide)cysteineN-Acetyl-S-(2-carbamoylethyl)-cysteine
n-acetyl-s-allylcysteineN-acetyl-S-allylcysteine
s-(3-hydroxypropyl)cysteine n-acetateN-Acetyl-S- (3-hydroxypropyl)-cysteine
s-trichlorovinyl-n-acetylcysteineN-Acetyl-S-(trichlorovinyl)-cysteine
zofenoprilA proline derivative that is 4-(phenylsulfanyl)-L-proline in which the amine proton is replaced by a (2S)-3-(benzoylsulfanyl)-2-methylpropanoyl group. A prodrug for zofenoprilat.zofenopril
zofenoprilateA proline derivative that is 4-(phenylsulfanyl)-L-proline in which the amine proton is replaced by a (2S)-2-methyl-3-sulfanylpropanoyl group. The active metabolite of zofenopril.zofenoprilat

Research

Studies (237)

TimeframeStudies, Drugs in This Class (%)All Drugs %
pre-199019 (8.02)18.7374
1990's52 (21.94)18.2507
2000's55 (23.21)29.6817
2010's92 (38.82)24.3611
2020's19 (8.02)2.80

Study Types

Publication TypeStudies, Drugs in This Class (%)All Drugs (%)
Trials42 (16.34%)5.53%
Reviews26 (10.12%)6.00%
Case Studies1 (0.39%)4.05%
Observational2 (0.78%)0.25%
Other186 (72.37%)84.16%